We have examined the effects of the protein kinase inhibitor KT5926 on NGF-promoted responses in PC1 2 and PC1 2X41 cells (a subclone of the parental cell line). Our findings reveal that this compound specifically and reversibly prevents the NGF-induced outgrowth and regeneration of neurites. In addition, neurites of NGF-pretreated cells cease further elongation upon exposure to KT5926. However, preexisting neurite networks in the cultures remain intact in the presence of the drug. The inhibition of neuritic growth appears to occur at least in part at the level of growth cones since KT5926 also causes these structures to collapse and inhibits NGFpromoted reactivation of NGF-deprived growth cones. Although KT5926 is an analogue of K-252a, which blocks all responses to NGF, it does not affect other NGF-elicited cellular responses examined, including NGF-dependent priming of cells, gp140mom autophosphorylation, immediate-early gene induction, and phosphorylation of several known cytoskeletal proteins (MAP 1.2/1B, chartin MAPS, and &tu-bulin). However, phosphate incorporation into a cytoskeletally localized 56 kDa phosphoprotein, designated pp56, is selectively reduced in KT5926-treated cultures (*NGF). Although KT5926 is an in vitro inhibitor of myosin light chain kinase and calmodulin-dependent protein kinase II, inhibition of these two kinase activities by ML-9 and KN-62, respectively, applied alone or together, does not mimic the effects of KT5926 on neurite growth and on pp56 phosphorylation.
Taken together, our findings suggest that KT5926, via a previously unidentified protein kinase inhibitory activity, differentially interferes with NGF-promoted growth cone function and consequently affects neuritic outgrowth. This compound should therefore be a useful tool for dissecting the mechanism of NGF actions and affords a means to identify phosphoproteins that play specific roles in neurite growth/elongation.
[Key words: cytoskeleton, growth cone, K-252a derivative, neuronal differentiation, PC 12 cells, PC 12X4 1 cells, protein kinase inhibitor, signal transduction] NGF is the prototypic and best studied example of the neurotrophin family of polypeptide growth factors (reviewed by LeviMontalcini and Angeletti, 1968; Ebendal, 1992) . NGF exhibits profound trophic and differentiation-promoting effects on specific neuronal populations in both the PNS and CNS (reviewed by Levi-Montalcini and Angeletti, 1968) . However, the underlying molecular mechanisms by which NGF and other neurotrophins exert their actions on target neurons remain largely undefined.
The rat pheochromocytoma PC 12 cell line (Greene and Tischler, 1976 ) is an NGF-responsive model system that has been useful for studying the underlying mechanisms of NGF actions (reviewed by Halegoua et al., 199 1; Levi and Alema, 1991) . PC 12 cells proliferate in serum-containing culture medium, and in many respects resemble their non-neoplastic adrenal chromaffin cell counterparts. When exposed to NGF, however, these cells withdraw from the cell cycle and gradually adopt many properties that are characteristic of mature sympathetic neurons (Greene and Tischler, 1982) . The most dramatic aspect of this response is the extension of long, axon-like neurites with actively motile growth cones (reviewed by Aletta et al., 1990) . The acquisition of a "neuronal" phenotype by PC 12 cells requires both transcription-dependent and -independent cellular responses to NGF (Burstein and Greene, 1978; Greene, 1984) . Transcription-dependent events include upregulation of selective cytoskeletal proteins (Leonard et al., 1988; Noble et al., 1989; Weinberger et al., 1993) and other neural markers (Dickson et al., 1986; Prentice et al., 1987) while relevant transcription-independent actions include regulation of cytoskeletal protein phosphorylation Black et al., 1986; Aletta and Greene, 1987; Aletta et al., , 1989 , promotion of growth cone motility (Seeley and Greene, 1983; Connolly et al., 1985; , and rapid regeneration of neurites (Burstein and Greene, 1978; . Stimulation of neuritogenesis by NGF is therefore a complex phenomenon composed of multiple individual responses (Aletta et al., 1990) .
Pharmacological agents that inhibit or mimic specific aspects of NGF actions have been particularly useful for dissecting the pleiotropic effects of this factor and thereby further understanding the NGF mechanism. Here we report that the protein kinase inhibitor KT59'26 (Nakanishi et al., 1990; Hashimoto et al, 199 1) prevents the outgrowth of neurites from a PC 12 cell line but does not interfere with other NGF-regulated events, such as priming, rapid gene induction, and phosphorylation of microtubule-associated proteins (MAPS). Our findings suggest that KT5926 may act to inhibit elongation of neurites differentially at least in part by suppressing NGF-promoted motility ofgrowth cones. This compound should aid future analysis of the mechanism by which NGF regulates neuritic outgrowth.
Materials and Methods
Reagents and materials. NGF (2.5s) was purified from adult mouse submaxillary glands according to Mobley et al. (1976) and used at concentrations of 50-100 rig/ml. The protein kinase inhibitors KT5926, (8R*, 9S*, 1 lS*)-(-)-9-hydroxy-9-methoxycarbonyl-8-methyl-l4-npropoxyl-2,3,9,10-tetrahydro-8,l l-epoxy,1 H,8H,l lH-2,7b,l la-triaiadibenzo[a,g]cycloocta[cde]trinden-l-one, and K-252a were purchased from Kamiva Biomedical ComDany, Thousand Oaks, CA, and were dissolved in himethyl sulfoxide (DMS.0) as concentrated stocks (5 mM and 1 mM, respectively). Inhibitors for myosin light chain kinase (MLCK) (ML-9) and calmodulin-dependent protein kinase II (CamKII) (KN-62) were purchased from Seikagaku America, Inc., Rockville, MD, and dissolved in DMSO (stock concentration; 10 mM for both inhibitors). Polyclonal antiserum against gp140pr0101rk (203-9; Soltoff et al., 1992) and monoclonal anti-phosphotyrosine antibody 4G 10 ( Kaplan et al., 1990) were generous gifts from Dr. David Kaplan (NCI, Frederick, MD) . Radiolabeling reagents were obtained from DuPont-New England Nuclear, Boston, MA. Protein concentration determination was carried out according to Bradford (1976) using reagents purchased from BioRad Laboratories, Richmond, CA.
Cell cultures. PC12-C41 cells are clonal variants of the PC12 cells that elaborate more abundant neurites in the presence of NGF. The establishment and characterization of the PC 12-C4 1 cell line have been described elsewhere .
PC 12 and PC 12"C4 1 cells were cultured on collagen-coated dishes in RPM1 1640 medium supplemented with 10% heat-inactivated horse serum and 5% fetal bovine serum (complete medium; Greene et al., 1987 . 199 1). For NGF treatment, cultures were plated at low density (5 x 'lo5 cells per 35 mm dish or l-2 x 10" cells per 100 mm dish) in comulete medium and NGF. Where anDlicable. various inhibitors were added directly (from concentrated sticks) to the medium. The carrier DMSO alone (up to 0.2% in complete medium) has no demonstrable effect on PC1 2 or PC1 2-C4 1 cell cultures.
Measurement of neurite outgrowth. Neurite-bearing cells were scored at high magnification (320x) as previously described (Greene and Tischler, 1976) . Only processes greater than 2 cell body diameters in length (i.e., about 20 pm) were considered neurites, and cells in the center of clumps that could not be adequately discerned were excluded. For each culture condition, at least 100 cells from randomly chosen fields were scored.
Neurite lengths were measured by the use of an eyepiece equipped with a calibrated micrometer and 20 random neurites were assessed per culture condition.
Neurite regeneration assays (see Figs. 2B, 3B) were carried out with NGF-primed cells (with or without KT5926 treatment during priming)
as previously described (Burstein and Greene, 1978) . At least 100 cells/ cell clumps per culture condition were scored for their abilities to regenerate neurites.
Assessment ofgrowth cone morphology. Cells were fixed (without prior removal of the culture medium) in paraformaldehyde by rapid, dropwise addition of 2 vol of 4% paraformaldehyde/PBS (prewarmed to 37°C) to 1 vol of the culture medium. The cultures were allowed to fix for 1 hr at 37°C before examination with phase-contrast optics under high magnification (320x). The morphologies of individual growth cones were classified either as "extended" or "collapsed" (as shown in Fig.  5A ,B, respectively). The percentages of extended growth cones under various culture conditions were determined on coded samples and were scored blind by the observer. At least 100 growth cones were examined per culture condition.
Metabolic labeling and subcellular fractionation. Metabolic radiolabeling of cell cultures with 50-300 PCi of 32P-orthophosphate was performed in 35 mm dishes in 1 ml of modified HEPES-buffered KrebsRinger solution by incubation for 2 hr at 37°C (Black et al., 1986) . Where applicable, the labeling medium contained NGF with or without various inhibitors. Total cellular extracts were prepared by directly harvesting the cells in 1 x SDS sample buffer (Laemmli, 1970) and boiling for 10 min. Subcellular fractionations were performed on '*P-labeled cells attached to 35 mm culture dishes to yield a Triton X-lOO-soluble fraction and a Ca2+-extractable/microtubule-enriched fraction as previously described (Solomon et al., 1979; Aletta and Greene, 1987; were included with molecular mass standards (Bio-Rad Laboratories) to indicate the positions of tubulins and MAP lB/1.2. The gels containing '*P-labeled proteins were fixed, stained, dried, and then exposed to Kodak XAR-5 x-ray film. Analysis of ,gpl40~'~~~~~~ tyrosine phosphorylation. Cell extracts were prepared and equal amounts of protein were subjected to immunoprecipitation with antiserum 203-9 against gp140~roto'rx (Soltoff et al., 1992;  used at 1:200 dilution) as described by Loeb et al. (1992) . The immunoprecipitates were resolved by SDS-PAGE on a 7.5% polyacrylamide gel and transferred onto supported nitrocellulose (S & S, Keene, NH)
according to Towbin et al. (1979) . The blot was then probed with antiphosphoiyrosine antibodies 4G16 (used at 1: 1 dilution in 3% BSA/PBS; kindlv nrovided bv Dr. David Kanlan. NCI. Frederick. MD) and the tyro&-phosphor$ated gp 140 pro*olf was detected with j50 nci of 1251-labeled goat anti-mouse IgG per milliliter of 3% BSA/PBS. Autoradiographic images were obtained by exposing the blot to Kodak XAR-5 x-ray film with an intensifying screen at -80°C.
Northern blotting analysis. Total cellular RNA was isolated according to Chomczynski and Sacchi (1987) . RNA was subjected to electrophoresis at 150 V on 1% agarose-formaldehyde gels and transferred to GeneScreen Plus membrane following the manufacturer's protocol (DuPont-New England Nuclear). The 32P-labeled probes for c-fos (Curran et al., 1982) and Tis-1 (Kujubu et al., 1987) were prepared by random priming reactions (Boehringer-Mannheim, Indianapolis, IN). Blots were hybridized overnight at 37°C with the radiolabeled probe and were washed at high stringency as described for GeneScreen Plus membrane. The equality of sample loading was verified by ethidium bromide staining.
Results
Compound KT5926 inhibits NGF-induced neurite outgrowth, but not priming To examine the potential effects of the protein kinase inhibitor KT5926 on neurite outgrowth, PC 12 and PC 12-C4 1 cells were exposed to NGF in the presence or absence of this compound. PC 12-C4 1 cells are a clonal variant line of PC1 2 cells that show significantly enhanced neuritogenic potential, but otherwise generally similar behavior . Figure 1B shows that in the absence of KT5926, NGF-treated PC 12-C4 1 cells elaborate abundant neurites. In contrast, as shown in Figure lD , 5 PM KT5926 substantially inhibits the formation of the neurite network even after the same long-term exposure (11 d) to NGF. This inhibition of neurite outgrowth was observed at all times of exposure to this drug (from 1 d to 2 weeks; data not shown). Note that KT5926 applied alone appears to induce a slight flattening of the cells (Fig. 1 C) . Comparable observations were achieved with PC12 cells (not shown). Because of its greater neuritogenic capacity, the bulk of the subsequent studies were carried out with the PC12-C41 cell subclone.
The inhibitory effect of KT5926 on neuritogenesis was quantified and is shown in Figure 2 . The data in Figure 2A show that only 3-5% of the cells treated with 5 PM KT5926 were neurite bearing after 11 d of treatment with NGF, whereas all of the control NGF-treated cells possessed neurites. To determine whether the inhibition of neurite growth by KT5926 is a nonspecific cytotoxic effect or is direct and reversible, a portion of the cultures treated with NGF plus KT5926 for 11 d were washed free of the compound (by rinsing three times with complete medium) and re-fed with complete medium containing only NGF, and the percentage of neurite-bearing cells was measured 3 d later. The results ( Fig. 2A) reveal that 80-90% of the cells extended neurites after washout of the inhibitor, indicating that KT5926 treatment is reversible and does not produce nonspecific reduction of cell viability. Since naive cells that were treated for a comparable period with 5 PM KT5926 alone did not extend neurites after washout of the drug (data not shown), the removal of KT5926 per se does not cause neurite extension.
We have previously shown that the time course of NGFdependent neuritogenesis by naive PC12 and PCl2-C41 cells exhibits an initial lag period followed by a prolonged rate of neurite appearance (Greene and Tischler, 1976; . In contrast, however, after NGF pretreatment, these cells regenerate long neurites after only 16-18 hr of NGF exposure (Burstein and Greene, 1978; . The observation that a large proportion of the cells treated with both KT5926 and NGF rapidly extended neurites with no apparent lag time after removal of the inhibitor ( Fig. 2A) suggested that the cells may be "primed" by NGF even in the continuous presence of KT5926. That is, while the drug may interfere with neurite outgrowth per se, it does not appear to affect the mechanisms that permit the cells to undergo NGF-dependent accumulation of materials needed to construct neurites (Greene, 1984) . To examine this issue directly, replicate cultures were pretreated with either NGF alone or with NGF plus 5 PM KT5926 for 14 d and then subjected to a neurite regeneration assay in the presence or absence of NGF and KT5926 (Fig. 2B) . Consonant with prior findings (Burstein and Greene, 1978; , cells pretreated with NGF alone rapidly regenerated neurites in an NGF-dependent manner. Moreover, a substantial number of cells pretreated with both NGF and KT5926 rapidly generated neurites when passaged into NGF-containing medium alone. Finally, KT5926 also substantially inhibited neurite regeneration/generation by cells primed with either NGF alone or with NGF plus the drug. Thus, KT5926 blocks regeneration as well as initiation of neurites, but does not appear to suppress NGF-dependent priming.
We next examined the dose dependence of inhibition of neurite growth by KT5926. Figure 3A reveals that KT5926 inhibits NGF-induced neurite outgrowth from naive cells in a doseperformed to determine whether this compound exhibits spedependent manner and that the half-maximal concentration for cific aspects of the former. We therefore added KT5926 (2.5 inhibition (IC,,) is =3 WM. Cytotoxicity was apparent only in and 5 MM) to cultures with preexisting neurites in the continued those cultures that were exposed to 10 I.LM KT5926 for more presence of NGF and measured the rate of process extension. than 1 week (data not shown). A dose-dependent inhibition of As shown in Figure 4 , although KT5926 does not cause retracneurite outgrowth by KT5926 was also observed in cultures tion of preexisting net&es, it substantially prevents their further maintained in serum-free medium, but the required concentraelongation. Note that the inhibitory effect is apparent even after tions were about lo-fold higher (data not shown). Finally, we 1 d of exposure to this compound. Consistent with the data in determined the KT5926 dose dependence for inhibition of neu- Figure 3 , the blockade of neurite growth by KT5926 is dose rite regeneration by NGF-primed cells. The results, as shown dependent in that a lower concentration of this compound is in Figure 3B , also indicate an IC,, of about 3 FM. less effective.
KT5926 blocks the actions of NGF on neurite elongation and growth cone morphology Since KT5926 appears to affect differentially the ability of NGF to induce neurite outgrowth but not priming, experiments were
Past studies have shown that NGF rapidly regulates growth cone morphology and motility (Seeley and Greene, 1983; Connolly et al., 1985 Connolly et al., , 1987 . In the presence of NGF, growth cones exhibit an extended, fan-shaped conformation and advance, whereas after NGF withdrawal they collapse into blunt-ended morphologies and cease movement (Seeley and Greene, 1983; Connolly et al., 1985 Connolly et al., , 1987 . Moreover, readdition of NGF to collapsed growth cones results in their rapid reattainment of a spread morphology and of motility (Seeley and Greene, 1983; Connolly et al., 1987; . To address whether KT5926 might exert its effects on neurite growth at least in part at the level of the growth cone, cultures were preincubated with NGF for 8 d and a portion were then treated overnight with NGF and KT5926. Scoring of the growth cones for extended or collapsed morphologies revealed that 80-90% were extended in cultures with NGF alone (Fig. 5A,C) , whereas 90% collapsed in cultures exposed to NGF and the drug (Fig. 5B,C) . Parallel cultures (after overnight NGF deprivation) were also assessed for the effects of NGF readdition (kKT5926). As shown in Figure 5C , readdition of NGF caused the anticipated return of extended growth cones, while exposure to KT5926, in either the presence or absence of NGF, completely prevented this effect. Although the neurites ceased elongation (Fig. 4) and appeared "beady" (Fig. 5B ) after KT5926 treatment, the existing neurite network in the cultures remained intact for at least a week of exposure to KT5926 plus NGF (data not shown). Taken together, the above findings indicate that KT5926 blocks NGFpromoted neurite generation and regeneration by interfering with process outgrowth, and does so at least in part at the level of the growth cone. Figure 5 . Effect of KT5926 on growth cone morphology. A and B, Replicate PC12-C41 cultures were treated with 100 rig/ml NGF for 9 d without (A) or with (B) 5 PM KT5926 present for the last 24 hr. Phase-contrast photomicrographs of growth cones show that most are extended in control NGF-treated cultures (A, arrows) whereas most are collapsed after 24 hr exposure to KT5926 (B, arrowheads). Scale bar, 20 pm. C, Quantitation of the effect of KT5926 on growth cone morphology. Replicate PC1 2X4 1 cultures were primed with NGF for 8 d. They were then washed three times with NGF-free complete medium and refed with complete medium with (IV) or without (0) NGF and with or without 5 PM KT5926 (K7') as indicated (pretreatment conditions). A portion of the cultures (NGF-treated, NGF-deprived, and NGF-treated plus KT5926) were fixed 24 hr later as described in Materials and Methods. The remaining cultures (NGF-deprived, and NGF-deprived but KT5926-treated) were cultured for an additional hour in the presence of 100 rig/ml NGF and then fixed. The morphologies of the growth cones under the indicated culture conditions were scored blind from coded samples and were designated as either extended or collapsed. The values represent averages of determinations on duplicate cultures (> 100 growth cones scored per culture), and error bars indicate range. Comparable results were obtained in an additional independent experiment.
KT5926 does not afeet the overall NGF signaling mechanism
It has been reported that K-252a is a potent and specific inhibitor of NGF-stimulated gp 1 40pmt*rk tyrosine kinase activity (Berg et al., 1992; Nye et al., 1992) and consequently blocks all responses of PC12 cells to NGF (Koizumi et al., 1988) . Since KT5926 is an n-propoxy derivative of K-252a (Nakanishi et al., 1990) , it is conceivable that this compound may affect NGFdependent neurite outgrowth by a similar mechanism involving the tyrosine kinase activity of the receptor. Therefore, we ex- previous reports (Berg et al., 1992; Nye et al., 1992) , 200 nM K-252a completely inhibits the NGF-dependent autophosphorylation of gpl 40prototrk. In contrast, the NGF-induced autophosphorylation of gp140pro101r4 was not affected by 6 PM KT5926.
To determine if KT5926 might significantly alter early downstream elements of the NGF signaling mechanism, we examined c-fos mRNA induction, which constitutes part of the early PC1 2 and PC12-C41 cellular responses to NGF (Greenberg et al., 1985; . Kujubu et al., 1987) , is also unaffected by KT5926 (data not shown).
KT5926 does not afect the phosphotylation of known NGFregulated cytoskeletal proteins Much evidence indicates that the cytoskeleton plays a critical role in NGF-induced neuritogenesis (Aletta et al., 1990 ). In particular, past studies have shown a correlation between NGFdependent neuritic outgrowth and the phosphorylation of p-tubulin (Black et al., 1986; Aletta and Greene, 1987) and specific MAPS such as chat-tins (Black et al., 1986; Aletta and Greene, 1987) and MAP 1.2/1B (Greeneet al., 1983; Alettaet al., 1988) . Because KT5926 is a protein kinase inhibitor and suppresses neurite outgrowth, we sought to determine whether this compound might inhibit the phosphorylation of specific cytoskeletal components. To test this possibility, naive or long-term (> 10 KT5926 Figure 7 . Induction of c-&s mRNA by NGF in KT5926-treated cell cultures. Replicate PC12-C41 cell cultures were pretreated overnight with 5 PM KT5926 and then exposed to 100 rig/ml NGF for the indicated times in the continued presence of the inhibitor. Replicate control cultures without KT5926 exposure were similarly treated with NGF. Total cellular RNA from each condition was isolated and subjected to Northern blotting analysis. Equal amounts (10 pg) of RNA were hybridized to a '*P-labeled probe for c-J& (arrow). All samples were from a single autoradiogram but were rearranged for clarity of presentation. Three independent experiments yielded comparable results. II, Phosphorylation of P-tubulin, chartin MAPS, and other Ca2+-releasable cytoskeletal proteins. Replicate cultures of naive or NGF-primed (22 d) PC 12-C4 1 cells were pretreated overnight with 5 PM KT5926. The cultures were then labeled (in the continued presence of drug) with 300 rCilm1 32P-orthophosphate for 3 hr. Subcellular fractionations were performed as described ) and the Ca*+-releasable MAP fraction
The Journal of Neuroscience, May 1994, 14 (5) 2631 d) NGF-treated cultures were exposed to 5 PM KT5926 for 16-20 hr, and then labeled with 32P-orthophosphate for 2-4 hr. Both whole-cell extracts and fractions enriched in Ca*+-releasable MAPS (released by Ca*+/cold from cells preextracted with Triton in an microtubule-stabilizing buffer; see Materials and Methods) were prepared and analyzed by SDS-PAGE and autoradiography. Representative autoradiograms are shown in Figure 8 . The data reveal that KT5926 exerts no appreciable effect on the phosphorylation states of P-tubulin (Fig. 84 , the chartin MAPS (Fig. 84 , or MAP 1.2/lB (Fig. SB) . KT5926 specifically reduces the phosphorylation level of pp58 Despite the lack of effect of KT5926 on known NGF-regulated cytoskeletal phosphoproteins, the labeling of an unidentified phosphoprotein of apparent M, 58,000 (~~58) in the Ca2+-releasable/MAP fractions of naive and NGF-treated cells is markedly reduced by this compound (Fig. 8B) . Scanning densitometry of a large number of independent experiments (n = 6) revealed that upon KT5926 exposure, pp58 labeling decreased by 36 + 10% and 60 + 16% in naive and NGF-primed cultures, respectively. In consonance with a previous report ) labeling of pp58 is slightly increased (= 30%) by NGF. We next determined the relative phosphorylation of pp58 after short-term exposure to KT5926. Replicate cultures of naive and long-term (> 10 d) NGF-primed cells were labeled with 32P-orthophosphate, treated with 5 PM KT5926 for 15 min or 2 d, extracted for Ca*+-releasable/MAPS, and analyzed by SDS-PAGE and autoradiography. The results (Fig. 94 indicate that 5 I.LM KT5926 significantly decreases the phosphate labeling of pp58 in both naive and NGF-treated cells after only 15 min of treatment. As noted above, the phosphorylations of fi-tubulin and chartins are not affected by this compound at both time points. Examination of the Triton-soluble fraction recovered from the same sets of cells reveals no effect on the vast majority of phosphate-labeled proteins with the consistent exception of a small reduction in labeling of a band that comigrates with pp58 (data not shown). Finally, the phosphoprotein labeling in the insoluble fractions (i.e., cellular materials remaining after the Triton and Caz+ extractions) from KT5926-treated and control cultures is indistinguishable (K. K. Teng and L. A. Greene, unpublished observation) . Thus far, therefore, the decrease in relative labeling of pp58 represents the only phosphorylation difference we have consistently detected by SDS-PAGE in cultures treated with KT5926.
The effects of KT5926 do not appear due to inhibition of myosin light chain kinase and/or calmodulin-dependent kinase ZZ Past work has indicated that KT5926, at concentrations similar to those used in this study, is an effective inhibitor of both MLCK (Nakanishi et al., 1990) and CamKII (Hashimoto et al., 199 1). We therefore examined whether other inhibitors of these two protein kinases might similarly affect the phosphorylation of pp58. As shown in Figure 9A , 10 PM ML-9 and KN-62 [cellpermeant specific inhibitors of MLCK (Ishikawa et al., 1988; Baorto et al., 1992) and CamKII (Tokumitsu et al., 1990; Ishii et al., 199 1) , respectively], when administered either separately or together, fail to decrease the relative phosphorylation of pp58 in naive or NGF-primed cultures. Furthermore, neither ML-9 nor KN-62 (each at 10 PM) alone (data not shown) or in combination (Fig. 9B ) significantly inhibit NGF-induced neuritogenesis.
Discussion
D&erential inhibition of NGF-promoted neurite elongation by KT5926
The present study investigates the effects of the protein kinase inhibitor KT5926 on cellular responses to NGF. Our data show that at low micromolar concentrations, KT5926 significantly prevents NGF-promoted neuritogenesis and neurite regeneration by PC 12 and PC 12-C4 1 cells. This suppression of neuritic outgrowth persists while the inhibitor is present and reverses upon its removal. In contrast to its actions on neurites, KT5926 does not significantly alter other NGF responses, including gp 1 40prototrk autophosphorylation, c-fos and Tis-I mRNA induction, or phosphorylation of MAPS and /3-tubulin. Moreover, KT5926 does not appear to interfere with NGF-promoted priming. "Priming" is a transcription-dependent process that appears to be due to the synthesis and accumulation of specific molecules required for neurite outgrowth (Greene, 1984) . These results therefore indicate that KT5926 inhibits a transcription-independent component of neuritogenesis. Of relevance to this, KT5926 treatment does not result in degeneration or withdrawal of neurites as occurs in response to NGF removal (Greene and Tischler, 1976; but rather affects their ability to elongate (Fig. 4) . This strongly suggests a specific interference by this compound with the NGF-regulated cellular machinery for neurite extension.
Growth cone spreading and motility are major components of the neurite extension machinery that are regulated by NGF in a transcription-independent manner (Seeley and Greene, 1983; Connolly et al., 1985 Connolly et al., , 1987 . Our data indicate that KT5926 causes preexisting, spread growth cones to attain a stubby, "collapsed" shape. In addition, this drug also prevents the reactivation of NGF-deprived growth cones that occurs upon NGF readdition. Prior studies (Seeley and Greene, 1983; have indicated that spread growth cones are motile and locomotive, whereas those in the collapsed conformation are nonmotile and do not advance. These results therefore reveal an inhibitory action of KT5926 on NGF-regulated growth cone behavior and suggest an attractive locus for the differential effect of this compound on neurite outgrowth. However, presently available information does not distinguish whether growth cone function represents the primary cellular target of KT5926, whether growth cone activity represents only one of multiple actions affected by this compound, or whether the observed growth cone effects represent secondary, indirect consequences of other actions of this drug.
Mechanistic considerations
KT5926 is structurally similar to a series of potent protein kinase inhibitors that includes the compounds K-252a and stau-rosporine (reviewed by Kntisel and Hefti, 1992) . KT5926 has itself been shown to be a potent protein kinase inhibitor that blocks MLCK (Nakanishi et al., 1990) and CamKII (Hashimoto et al., 199 1) in vitro. Thus, it seems highly likely that the capacity of this drug to suppress NGF-promoted neuritogenesis is attributable to its kinase inhibitory activity. A number of compounds have been identified that inhibit neurite outgrowth from NGF-treated PC 12 cells and many of these are also blockers of protein kinase activity. KT5926, however, seems distinct in site of action from such agents. For instance, our data show that KT5926 clearly contrasts with K-252a (Kntisel and Hefti, 1992) , which blocks all actions of NGF (Koizumi et al., 1988) and appears to do so by selectively inhibiting the tyrosine kinase activity of the gp140pr010"k NGF receptor (Berg et al., 1992; Nye et al., 1992) . KT5926 is also distinct from 5'-S-methyl adenosine, which blocks all NGF responses (Seeley et al., 1984) . Moreover, unlike 2-aminopurine, which blocks at least several protein kinases (Volontt and Greene, 1992) or 6-thioguanine, which selectively inhibits the NGF-activated protein kinase N (Volonte et al., 1989 ) KT5926 does not appear to affect the induction of immediate-early genes by NGF (Batistatou et al., 1992 ; present study). In addition, KT5926 differs from inhibitors of protein tyrosine kinase, such as genistein, which promote neurite outgrowth in the absence of NGF (Miller et al., 1993) . Finally, although KT5926 appears to resemble Li+ (Burstein et al., 1985) in selectively affecting neurite outgrowth, it is distinct in mechanism in that it does not suppress phosphorylation of the chartin MAPS.
While past work has indicated that KT5926 inhibits MLCK (Nakanishi et al., 1990) and CamKII (Hashimoto et al., 1991) in selective cell types, these activities do not appear to account for the capacity of this compound to suppress neurite outgrowth. We found that other well-characterized inhibitors of MLCK and CamKII [ML-9 (Ishikawa et al., 1988; Baorto et al., 1992) and KN-62 (Tokumitsu et al., 1990; Ishii et al., 199 l) , respectively] display no demonstrable effects on NGF-promoted neuritogenesis. Previous studies (Tokumitsu et al., 1990; Ishii et al., 199 1) reported that KN-62 (at concentrations similar or lower than that used here) effectively abolishes CamKII-dependent responses in PC12 cells. Similarly, studies regarding ML-9 or its inhibition of MLCK indicated that this compound is quite effective in a variety of cell types (Ishikawa et al., 1988; Baorto et al., 1992) . Moreover, the calmodulin antagonist calmidazolium (which would also be expected to suppress CamKII and MLCK activities; Van Belle, 198 1; Sobieszek, 1989; Bading et al., 1993) does not appear to affect NGF-promoted neurite growth substantially (K. K. Teng, unpublished observations). These considerations thus suggest that KT5926 prevents neuritogenesis independently from its actions on CamKII and MLCK. This is further supported by our observation that unlike KT5926, KN-62 and ML-9 do not affect the phosphate labeling of pp58. The ability of compounds such as KT5926 to inhibit activities other than, or in addition to, those defined in vitro has a precedence. K-252a was initially defined in vitro as a selective protein kinase C inhibitor (Kase et al., 1986) but, as noted above, was subsequently shown to inhibit gp140pr010trk tyrosine kinase activity in intact cells (Berg et al., 1992; Nye et al., 1992) . Finally, like K-252a (Koizumi et al., 1988 ) and a structurally similar compound, staurosporine (Hashimoto and Hagino, 1989 ) KT5926 does not exert an inhibitory effect on basic fibroblast growth factor-induced neurite outgrowth from PC1 2 or PC12-C4 1 cells. Taken together, our results suggest that KT5926 may suppress NGF-regulated neurite outgrowth via inhibition of a hitherto unidentified protein kinase.
KT5926 and pp58
The most salient effect of KT5926 on PC 12-C4 1 cell phosphoproteins was to diminish the phosphate labeling of a 58 kDa component. This change occurred among a background of at least 30 other species whose incorporation of phosphate was unaffected by KT5926. Preliminary experiments have also revealed that KT5926 has no effect on the vast majority of phosphoproteins resolved by two-dimensional isoelectric focusing x SDS-PAGE (K. K. Teng and J. M. Angelastro, unpublished observations) or on proteins from NGF-treated cells detected with anti-phosphotyrosine antibody in Western immunoblots (Teng, unpublished observations) . Thus, KT5926 is not a general inhibitor of protein phosphorylation and its actions therefore appear to affect at most a restricted subset of cell phosphoproteins. This is consistent with the suggestion that the biologically relevant target of KT5926 is a protein kinase with a limited number of substrates.
Although the identity of pp58 is presently unclear, subcellular fractionation indicates its presence in both Triton-soluble and Ca2+-releasable/MAP fractions (predominantly in the latter fraction). This distribution distinguishes pp58 from tyrosine hydroxylase, a major soluble phosphoprotein of PC12 cells of apparent M, 59-60 kDa (Nose et al., 1985) . We do not presently know whether the effects of KT5926 on pp58 are causally related to the actions of this drug on neurite outgrowth. Recently, we reported that elevated K+ prevents neurites of NGF-deprived PC1 2 and PC12-C41 cells from degenerating, but that these depolarization-maintained neurites do not continue to elongate . Of possible relevance here, under such culture conditions, the phosphorylation of pp58 was also reduced .
In conclusion, we have shown here that the protein kinase inhibitor KT5926 differentially suppresses NGF-dependent neurite outgrowth and affects growth cone functions. This drug appears to mediate its actions via novel cellular targets that include pp58. It is quite conceivable that additional KT5926-sensitive proteins remain to be detected and that one or more of these plays a critical functional role in neurite outgrowth.
